Table 3. MIC50 and MIC90 of S. Typhi (n = 77) and S. Paratyphi A (n = 25) isolates from Kolkata, 2009 to 2013.
Antimicrobial agents | MIC Range (µg/ml) | MIC50 (µg/ml) | MIC90 (µg/ml) | MIC (µg/ml) breakpoint for resistancec | |||
STa | SPAb | STa | SPAb | STa | SPAb | ||
Ampicillin | 0.094–≥256 | 1–3 | 0.5 | 1.5 | ≥256 | 3 | ≥32 |
Chloramphenicol | 1.5–≥256 | 4–8 | 2 | 6 | ≥256 | 8 | ≥32 |
Co-trimoxazole | 0.008–≥32 | 0.032–0.125 | 0.023 | 0.094 | ≥32 | 0.125 | ≥4 |
Tetracycline | 1–16 | 1.5–4 | 1.5 | 3 | 3 | 4 | ≥16 |
Nalidixic acid | 2–≥256 | 1.5–≥256 | ≥256 | ≥256 | ≥256 | ≥256 | ≥32 |
Ciprofloxacin | 0.064–≥32 | 0.032–0.75 | 0.38 | 0.5 | ≥32 | 0.75 | ≥1 |
Ofloxacin | 0.047–≥32 | 0.125–4 | 0.75 | 2 | 24 | 3 | ≥2 |
Levofloxacin | 0.023–24 | 0.064–1 | 0.25 | 0.75 | 4 | 1 | ≥2 |
Ceftriaxone | 0.032–0.19 | 0.064–0.19 | 0.064 | 0.125 | 0.125 | 0.19 | ≥4 |
Ceftazidime | 0.064–0.38 | 0.19–0.75 | 0.19 | 0.38 | 0.38 | 0.5 | ≥16 |
Cefotaxime | 0.023–0.125 | 0.125–0.25 | 0.064 | 0.19 | 0.094 | 0.19 | ≥4 |
Azithromycin | 1.5–16 | 3–32 | 8 | 16 | 12 | 32 | >16 |
Amoxicillin/clavulanic acid | 0.25–≥256 | 0.75–3 | 0.5 | 1.5 | 32 | 1.5 | ≥32 |
ST, S. Typhi.
SPA, S. Paratyphi A.
CLSI, 2013 guideline followed for all antimicrobials except azithromycin.